Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Caribou Biosciences Inc (CRBU)

132 + Investors. Track Smart Money conviction in CRBU. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +12
Streak
2Q ▲
Buyers last Q
51%

Smart Money Signals — CRBU

Based on 133 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added CRBU than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 91% of 3.0Y peak

91% of all-time peak
133 funds currently hold this stock — 91% of the 3.0-year high of 146 funds (reached 2024 Q1). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding CRBU is almost the same as a year ago (+2 funds, +2% change). No significant rush to buy or sell — institutional backing is holding steady.
🟡

Slight buying edge — 51% buying

56 buying53 selling
Last quarter: 56 funds bought or added vs 53 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+6 vs last Q)

new funds entering per quarter
Funds opening a new CRBU position: 33 → 17 → 21 → 27. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

43% of holders stayed for 2+ years

■ 43% conviction (2yr+) ■ 31% medium ■ 26% new
57 out of 133 hedge funds have held CRBU for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
➡️

Steady discovery — ~27 new funds/quarter

20 → 33 → 17 → 21 → 27 new funds/Q
New funds entering each quarter: 33 → 17 → 21 → 27. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Deep conviction — 54% of holders stayed 2+ years

■ 54% veterans ■ 17% 1-2yr ■ 29% new
Of 138 current holders: 75 (54%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 25% AUM from major funds

25% from top-100 AUM funds
33 of 133 holders rank in the top 100 by AUM, accounting for 25% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.2
out of 10
Low Exit Risk
Exit risk score 3.2/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CRBU

In 2026 Q1, 56 hedge funds were net buyers of CRBU (27 opened a new position, 29 added to an existing one), while 53 reduced or exited (38 trimmed, 15 sold completely) — a 51% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 25% of total institutional value in CRBU is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +12 funds (more new holders than closures). Total institutional holders: 133.

Hedge Fund Ownership: CRBU

How many hedge funds hold CRBU — quarterly history vs. share price
Quarterly hedge fund ownership of CRBU vs. share price

Market Analysis: CRBU

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CRBU

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Caribou Biosciences Inc (CRBU) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much CRBU has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 80d ago
CRBU
nan%
XLV
+2.1%

CRBU outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 35d ago
CRBU
nan%
XLV
+3.2%

Since the filing became public, CRBU outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

12 top-rated funds 1 high-conviction
Consensus
4.8
/ 10
breadth
×
Elite
1.1
/ 10
conviction
Hedge Fund Positioning: CRBU
132 + Investors

Track Smart Money conviction in CRBU. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 132 121 9.09%
13F Shares 39M 37M 5.38%
Total Value $70M $59M 18.45%
New Positions 26 21 +5
Increased Positions 26 29 -3
Closed Positions 15 17 -2
Reduced Positions 38 37 +1
Total Calls 3 3 -
Total Puts 2 2 -
PUT/CALL Ratio 0.67 0.67 Bullish

Statistics: CRBU

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

132 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CRBU. Verified SEC 13F-HR filings.

QUARTER:
Top 25 CRBU holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Pfizer Inc 3.50% 4,690,431 $8.3M
2 72 Investment Holdings, LLC 1.82% 474,067 $901K
3 Green Alpha Advisors, LLC 0.70% 373,650 $710K
4 Kynam Capital Management, LP 0.29% 2,503,302 $4.8M
5 Nano Cap New Millennium Growth Fund L P 0.21% 117,500 $223K
6 PFM Health Sciences, LP 0.17% 957,787 $1.8M
7 Bruce & Co., Inc. 0.14% 250,000 $475K
8 CTC Alternative Strategies, Ltd. 0.07% 15,076 $29K
9 Milestone Asset Management, LLC 0.06% 162,076 $308K
10 Diametric Capital, LP 0.02% 32,793 $62K
11 Maverick Capital Ltd 0.01% 652,542 $1.2M
12 Nelson Capital Management, LLC 0.01% 58,685 $112K
13 Next Capital Management LLC 0.01% 20,000 $38K
14 XTX Topco Ltd 0.01% 323,469 $615K
15 Keystone Financial Group 0.01% 80,475 $153K
16 Catalyst Funds Management Pty Ltd 0.01% 32,200 $61K
17 Westmount Partners, LLC 0.01% 19,609 $37K
18 Thrive Wealth Management, LLC 0.01% 32,000 $61K
19 Renaissance Technologies LLC 0.01% 2,590,497 $4.9M
20 NINE MASTS CAPITAL Ltd 0.01% 20,612 $39K
21 Bridgeway Capital Management, LLC 0.01% 132,000 $251K
22 Liberty Wealth Management LLC 0.00% 19,500 $37K
23 RBF Capital, LLC 0.00% 40,000 $76K
24 Aberdeen Group plc 0.00% 1,212,541 $2.3M
25 Axq Capital, LP 0.00% 15,000 $28K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Caribou Biosciences Inc (CRBU)

What does the Smart Money Trend signal show for CRBU?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added CRBU than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CRBU?

Slight buying edge — 51% buying: Last quarter: 56 funds bought or added vs 53 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CRBU holders?

Strong quality — 25% AUM from major funds: 33 of 133 holders rank in the top 100 by AUM, accounting for 25% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held CRBU?

43% of holders stayed for 2+ years: 57 out of 133 hedge funds have held CRBU for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Caribou Biosciences Inc (CRBU) following the 2026 Q1 hedge fund 13F filings?

As of today, CRBU has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), CRBU has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →